Convergence is an invitation-only gathering of one hundred pharmaceutical executives, biotech entrepreneurs, medical device innovators, academic researchers, and life sciences investors from the Northeast and beyond. Request an invitation.

Companies that were represented at Convergence 2008 included:

Adimab, Inc. J. Robert Scott
Adnexus Therapeutics Koch Inst. for Integ. Cancer Rsh.
Aileron Therapeutics Lux Capital Management
Alantos Pharmaceuticals MacDougall Biomed. Comm.
Alexandria Real Estate Equities Magen BioSciences
Alkermes Mascoma
AstraZeneca Massachusetts Biotech Council
Atlantic Healthcare Ltd. Mass Eye and Ear Infirmary
Aura Biosciences Mass High Tech
Avecia Biotechnology MDinteractive
AVEO Pharmaceuticals, Inc. Medtronic, Inc.
BaroFold Millennium Pharmaceuticals
BayCross Capital Partners, LLC Mintz Levin
BIND BioiSciences MP Healthcare Venture Management
BIO Ventures for Global Health MPM Capital 
BioScale Neurotech
BioTrove New England Healthcare Institute
Boston Scientific Norwich Ventures
CBT Advisors Novartis Venture Funds
CIMIT OmniSonics Medical Technologies
Co-Bio Consulting, LLC Oxford Bioscience Partners
CombinatoRx Partners Innovation Fund
Concert Pharmaceuticals Peptimmune
Covington Associates Pfizer Global R&D
Cyberkinetics Polaris Venture Partners
Cytel Inc. RA Capital Associates
Dicerna Pharmaceuticals Radius Health, Inc.
EGS Healthcare Capital Partners RiboNovix, Inc.
Elixir Pharmaceuticals, Inc. RMG Associates
Enanta Pharmaceutical, Inc. Scientia Advisors
Fate Therapeutics Scisive Consulting LLC
Fidelity Biosciences Slater Technology Fund
Flagship Ventures Strategic Sciences and Technologies
Foley & Lardner LLP SVB Silicon Valley Bank
Gene Network Sciences Synta Pharmaceuticals 
Genocea Biosciences Targanta Therapeutics Corporation
Genzyme Corp. Targacept, Inc.
GI Dynamics The Boston Globe
GreenFuel Technologies Corp. The Michael J. Fox Foundation
Hambrecht & Quist Capital Mgmt TheraGenetics, Ltd.
Halloran Conuslting Group Third Rock Ventures
Harvard University TransMolecular, Inc.
Histogenics Corporation Transport Pharmaceuticals
iBall, Inc. TVM Capital
IDA Ireland UCSF
Infinity Pharmaceuticals, Inc. Verenium Corporation
Inotek Pharmaceuticals Corp. WMR Biomedical, Inc.
Ironwood Pharmaceuticals Wolfe Laboratories, Inc.